| COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2 A Mittal, K Manjunath, RK Ranjan, S Kaushik, S Kumar, V Verma PLoS pathogens 16 (8), e1008762, 2020 | 350 | 2020 |
| New functions for the ancient DedA membrane protein family WT Doerrler, R Sikdar, S Kumar, LA Boughner Journal of bacteriology 195 (1), 3-11, 2013 | 85 | 2013 |
| A novel resveratrol based tubulin inhibitor induces mitotic arrest and activates apoptosis in cancer cells E Thomas, V Gopalakrishnan, M Hegde, S Kumar, SS Karki, ... Scientific reports 6 (1), 34653, 2016 | 72 | 2016 |
| COVID-19 mechanisms in the human body—What we know so far A Kumar, RK Narayan, P Prasoon, C Kumari, G Kaur, S Kumar, ... Frontiers in immunology 12, 693938, 2021 | 70 | 2021 |
| Cardiomyocyte culture—An update on the in vitro cardiovascular model and future challenges S Parameswaran, S Kumar, RS Verma, RK Sharma Canadian Journal of Physiology and Pharmacology 91 (12), 985-998, 2013 | 56 | 2013 |
| Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines J Koroth, S Nirgude, S Tiwari, V Gopalakrishnan, R Mahadeva, S Kumar, ... BMC complementary and alternative medicine 19, 1-16, 2019 | 51 | 2019 |
| Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials B Goel, AK Tiwari, RK Pandey, AP Singh, S Kumar, A Sinha, SK Jain, ... Translational oncology 21, 101426, 2022 | 49 | 2022 |
| Mechanism of BRAF activation through biochemical characterization of the recombinant full‐length protein N Cope, C Candelora, K Wong, S Kumar, H Nan, M Grasso, B Novak, Y Li, ... ChemBioChem 19 (18), 1988-1997, 2018 | 41 | 2018 |
| Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19 A Kumar, R Parashar, S Kumar, MA Faiq, C Kumari, M Kulandhasamy, ... Journal of Medical Virology 94 (4), 1300-1314, 2022 | 39 | 2022 |
| Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents U Das, S Kumar, J R Dimmock, R K Sharma Current Cancer Drug Targets 12 (6), 667-692, 2012 | 35 | 2012 |
| COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes A Kumar, RK Narayan, M Kulandhasamy, P Prasoon, C Kumari, S Kumar, ... Expert Reviews in Molecular Medicine 23, e7, 2021 | 20 | 2021 |
| N-myristoyltransferase in the leukocytic development processes S Kumar, B Singh, JR Dimmock, RK Sharma Cell and tissue research 345, 203-211, 2011 | 15 | 2011 |
| N-Terminal Region of the Catalytic Domain of Human N-Myristoyltransferase 1 Acts as an Inhibitory Module S Kumar, RK Sharma PLoS One 10 (5), e0127661, 2015 | 14 | 2015 |
| Impact of comorbidities on patients with Covid-19 in India: A Nationwide Analysis P Singh, Y Bhaskar, P Verma, S Rana, P Goel, S Kumar, KC Gouda, ... Frontiers in Public Health 10, 2023 | 13 | 2023 |
| The Potential Use of N-Myristoyltransferase as a Biomarker in the Early Diagnosis of Colon Cancer S Kumar, JR Dimmock, RK Sharma Cancers 3 (1), 1372-1382, 2011 | 13 | 2011 |
| Demographic characteristics of SARS-CoV-2 B. 1.617. 2 (Delta) variant infections in Indian population A Kumar, A Asghar, K Raza, RK Narayan, RK Jha, A Satyam, G Kumar, ... MedRxiv, 2021.09. 23.21263948, 2021 | 11 | 2021 |
| Novel myristoylation of the sperm-specific hexokinase 1 isoform regulates its atypical localization S Kumar, S Parameswaran, RK Sharma Biology Open 4 (12), 1679-1687, 2015 | 9 | 2015 |
| NMT1 (N-myristoyltransferase 1) P Selvakumar, S Kumar, JR Dimmock, RK Sharma Atlas of genetics and cytogenetics in oncology and haematology 15 (7), 570, 2011 | 9 | 2011 |
| An improved method and cost effective strategy for soluble expression and purification of human N-myristoyltransferase 1 in E. coli S Kumar, RK Sharma Molecular and cellular biochemistry 392, 175-186, 2014 | 7 | 2014 |
| Polysaccharides of Pseudomonas Pathovar Strains That Infect Pea, Tomato, and Soya Bean S Datta, RS Kumar, N Ayyadurai, S Kumar, N Sakthivel Current microbiology 49, 35-41, 2004 | 7 | 2004 |
Rajenda K. SharmaUniversity of SaskatchewanVerified email at usask.ca
